
Ko-143
CAS No. 461054-93-3
Ko-143( Ko143 )
Catalog No. M14552 CAS No. 461054-93-3
A nontoxic analog of fungal toxin fumitremorgin C and potent, orally bioavailable inhibitor of BCRP (ABCG2) with EC90 of 26 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 35 | In Stock |
![]() ![]() |
5MG | 58 | In Stock |
![]() ![]() |
10MG | 102 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameKo-143
-
NoteResearch use only, not for human use.
-
Brief DescriptionA nontoxic analog of fungal toxin fumitremorgin C and potent, orally bioavailable inhibitor of BCRP (ABCG2) with EC90 of 26 nM.
-
DescriptionA nontoxic analog of fungal toxin fumitremorgin C and potent, orally bioavailable inhibitor of BCRP (ABCG2) with EC90 of 26 nM; shows low activity against P-gp, MRP1 and other known drug transporter; has an effect on the transport activity of both ABCB1 and ABCC1 at >1 uM; reverses Bcrp-mediated drug resistance and markedly increases the oral availability of topotecan in mice.
-
In Vitro——
-
In Vivo——
-
SynonymsKo143
-
PathwayMembrane Transporter/Ion Channel
-
TargetBCRP
-
RecptorBCRP
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number461054-93-3
-
Formula Weight469.5732
-
Molecular FormulaC26H35N3O5
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(OC(C)(C)C)CC[C@@H]1NC([C@]2([H])CC3=C([C@H](CC(C)C)N2C1=O)NC4=C3C=CC(OC)=C4)=O
-
Chemical NamePyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid, 1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxo-, 1,1-dimethylethyl ester, (3S,6S,12aS)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Allen JD, et al. Mol Cancer Ther. 2002 Apr;1(6):417-25.
2. Weidner LD, et al. J Pharmacol Exp Ther. 2015 Sep;354(3):384-93.
3. Ozvegy-Laczka C, et al. J Biol Chem. 2005 Feb 11;280(6):4219-27.
4. Elkind NB, et al. Cancer Res. 2005 Mar 1;65(5):1770-7.
molnova catalog



related products
-
YHO-13351 free base
YHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
-
KS-176
A potent and selective inhibitor of BCRP multidrug transporter with IC50 of 0.59 and 1.39 uM in Pheo A and Hoechst 33342 assays, respectively.
-
CP-100356 hydrochlor...
CP-100356 hydrochloride is an orally active, low micromolar dual inhibitor of MDR1 (P-gp) and BCRP, a nucleotide-derived substrate analogue that inhibits MDR1-mediated Calcein-AM and BCRP-mediated Prazosin transporters.